LINC00649: A Drug Target / Disease Biomarker (G100506334)

Target Name: LINC00649

NCBI ID: G100506334

LINC00649

Other Name(s): lnc-ITSN1-2 | Long intergenic non-protein coding RNA 649, transcript variant 1 | long intergenic non-protein coding RNA 649 | LINC00650

LINC00649: A Drug Target / Disease Biomarker

LINC00649 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to play a role in the regulation of inflammation and immune response. As a drug target, LINC00649 is a potential target for the development of new treatments for a variety of diseases.

The protein LINC00649 is characterized by its cytoplasmic density and its ability to interact with various signaling pathways. It is found in a variety of tissues throughout the body, including the brain, heart, and kidneys. It is expressed in the brain, where it is involved in the regulation of synaptic plasticity and the maintenance of neuronal structure. It is also found in the heart, where it is involved in the regulation of contractility and heart rate. Additionally, it is found in the kidneys, where it is involved in the regulation of water and electrolyte balance.

One of the key functions of LINC00649 is its role in the regulation of inflammation and immune response. It is known to play a role in the regulation of T cell development and function, as well as the regulation of immune cell proliferation and differentiation. This makes it a potential target for the development of new treatments for autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.

Another function of LINC00649 is its role in the regulation of cell death and survival. It is known to play a role in the regulation of apoptosis, or programmed cell death, which is a natural process that helps to remove damaged or dysfunctional cells from the body. This makes it a potential target for the development of new treatments for a variety of diseases, including cancer.

In addition to its role in the regulation of inflammation and immune response, LINC00649 is also known to play a role in the regulation of stem cell proliferation and differentiation. This makes it a potential target for the development of new treatments for a variety of diseases, including cancer.

Given its involvement in the regulation of inflammation and immune response, LINC00649 is a potential drug target for the development of new treatments for a variety of diseases. Studies are being conducted to determine the exact function of LINC00649 and its potential as a drug target. As more research is done, it is likely that LINC00649 will be found to have a wide range of potential applications in medicine.

Protein Name: Long Intergenic Non-protein Coding RNA 649

The "LINC00649 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00649 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets